Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure

-- Almost half of the world’s population has no or limited access to diagnostics

-- This situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIV

-- New partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treated

Read More →

Roche expands the Global Access Program beyond HIV to also include diagnostic tests for TB, hepatitis and HPV

-- Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals
-- Improving access to reliable diagnostics for disease management in countries with the highest burden
-- Early detection of infectious diseases with diagnostics helps clinicians save lives

Read More →

New Roche test aids clinicians in accelerating TB diagnosis and treatment by detecting antimicrobial resistance within the world's leading cause of infectious disease deaths

-- New tests on cobas 6800/8800 systems provide clinicians information to help speed treatment and reduce the spread of infection
-- Rising challenge of drug resistance compounds the tuberculosis global health crisis
-- Mycobacteria test menu allows detection of tuberculosis, drug resistant tuberculosis and nontuberculous mycobacteria infections from single patient sample

Read More →

Page 1 of 1 · Total posts: 3